↓ Skip to main content

Dove Medical Press

Self-initiation of antiretroviral therapy in the developing world: the involvement of private pharmacies in an HIV program

Overview of attention for article published in Drug, Healthcare and Patient Safety, March 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
49 Mendeley
Title
Self-initiation of antiretroviral therapy in the developing world: the involvement of private pharmacies in an HIV program
Published in
Drug, Healthcare and Patient Safety, March 2012
DOI 10.2147/dhps.s23653
Pubmed ID
Authors

Omary Mashiku Minzi, Deus Buma, Godeliver A Kagashe

Abstract

Self-initiation to antiretroviral treatment (ART) exposes the patient to the risk of drug toxicity, poor adherence to treatment, and escalates the development of drug resistance.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 18%
Student > Bachelor 6 12%
Student > Ph. D. Student 6 12%
Lecturer 4 8%
Student > Postgraduate 4 8%
Other 10 20%
Unknown 10 20%
Readers by discipline Count As %
Medicine and Dentistry 13 27%
Nursing and Health Professions 7 14%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Agricultural and Biological Sciences 3 6%
Immunology and Microbiology 3 6%
Other 8 16%
Unknown 10 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 June 2012.
All research outputs
#16,868,837
of 25,584,565 outputs
Outputs from Drug, Healthcare and Patient Safety
#110
of 156 outputs
Outputs of similar age
#107,869
of 168,428 outputs
Outputs of similar age from Drug, Healthcare and Patient Safety
#2
of 2 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,428 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.